Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000013469 | SCV001138016 | uncertain significance | Corneal dystrophy, Fuchs endothelial, 6 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002225264 | SCV002504023 | likely benign | not provided | 2018-07-31 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Labcorp Genetics |
RCV002225264 | SCV003254121 | benign | not provided | 2023-12-19 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV004017235 | SCV004848342 | likely benign | not specified | 2024-04-18 | criteria provided, single submitter | clinical testing | The p.Gln841Pro variant in ZEB1 is classified as likely benign because it has been identified in 3.5% (372/10606) of Finnish chromosomes, including 6 total homozygotes by gnomAD (http://gnomad.broadinstitute.org, v.4.0.0). ACMG/AMP Criteria applied: BS1. |
OMIM | RCV000013469 | SCV000033716 | pathogenic | Corneal dystrophy, Fuchs endothelial, 6 | 2010-01-01 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000013469 | SCV001142409 | uncertain significance | Corneal dystrophy, Fuchs endothelial, 6 | 2020-01-06 | no assertion criteria provided | curation | The ZEB1 gene is known as TCF8 in the published literature (PMID: 20036349). NM_030751.5:c.2519A>C in the ZEB1 gene has an allele frequency of 0.033 in European (Finnish) subpopulation in the gnomAD database. 22 homozygous occurrences are observed in the gnomAD database. Since the Fuchs Corneal Dystrophy was reported as Late-Onset, we determined to not apply the number of homozygousity as a strong benign evidence. Gupta et al reported an individual with fuchs endothelial corneal dystrophy harboing this variant (PMID: 26622166). In addition, Riazuddin et al. reported segregation of p.Q840P mutation in a large, multigenerational FCD pedigree, and concluded this allele to be sufficient but not necessary for pathogenesis. However, the author also stated that a second, independent genetic event might account for the phenotype in the other patients having not this variant (PMID: 20036349). We interpret it as variant of uncertain significance (VUS). ACMG/AMP criteria applied: BS1, PP4. |